Fingerprint
Dive into the research topics of 'A Phase II Study Investigating Cabozantinib in Patients with Refractory Metastatic Colorectal Cancer (AGICC 17CRC01)'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
AJ Scott, AB Mallick, E Dotan, SJ Cohen, PJ Gold, HS Hochster, S Subramaniam, A Barzi, GS Watts, PJ Blatchford, WA Messersmith
Research output: Contribution to conference › Paper › peer-review